Recovery from liraglutide-induced acute liver injury assessed for causality using the updated RUCAM as global gold standard: A case report and literature review
Int. Journal of Clinical Pharmacology and Therapeutics · 13.10.2026
DOI: 10.5414/cp205028 ↗Kurz gefasst
Fallbericht in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 13.10.2026. Verfasst von Fenli Su und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Su, F., & Lu, W. (2026). Recovery from liraglutide-induced acute liver injury assessed for causality using the updated RUCAM as global gold standard: A case report and literature review. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp205028
Vancouver
Su F, Lu W. Recovery from liraglutide-induced acute liver injury assessed for causality using the updated RUCAM as global gold standard: A case report and literature review. Int. Journal of Clinical Pharmacology and Therapeutics. 2026. doi:10.5414/cp205028
BibTeX
@article{Su2026,
author = {Su, Fenli and Lu, WeiChi},
title = {Recovery from liraglutide-induced acute liver injury assessed for causality using the updated RUCAM as global gold standard: A case report and literature review},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
doi = {10.5414/cp205028}
}
EUVIMED